NewsRoom Articles - Page 186 of 221

FridayJan 22, 2021 2:30 pm

Artificial Intelligence Could Improve IVF Outcomes

A study conducted in 2017 forecasted that artificial intelligence (AI) could extensively improve health-care results by 30–40%. AiVF, an Israeli ML company, has suggested that artificial intelligence bears the potential to grow the success rate of IVF by almost three times when compared to conventional methods. It should be noted, however, that pregnancy is dependent on other factors, such as age. IVF, or in vitro-fertilization, is a series of procedures that involves the extraction of mature ova from a woman’s body, which are then fertilized in a lab setting with sperm in a liquid. The fertilized ovum is then implanted…

FridayJan 22, 2021 2:28 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Disrupting Global Agricultural Markets

Company shares update of biopesticide product pipeline MGROF committed to combating deadly crop diseases, pests in Colombia and North America MustGrow touts potential additional uses as bioherbicide, sprout suppressor MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops and other markets, recently provided an update of its biopesticide product pipeline (https://ibn.fm/eOTGT). By extracting natural compounds from within the mustard seed — the mustard plant’s natural defense mechanism — the company has provided natural solutions to potentially replace widely used harmful synthetics that are being banned and deregistered. As…

ThursdayJan 21, 2021 12:45 pm

Tired of Dairy? Tel Aviv Researchers May Have Just What You Need, Milk From Yeast!

A researcher from Tel Aviv University has developed a way to produce dairy products from yeast. Professor Tamir Tuller from the university’s Department of Biomedical Engineering is the researcher behind this innovative development. Tuller worked together with Dr. Eyal Iffergan, a food technology entrepreneur, to set up Imagindairy, a start-up company that plans to make cow’s milk using yeast. This development comes at a time when researchers are working on finding substitutes for milk because dairy farming damages not only the environment but also human health. Tuller explained that Imagindairy’s objective was to create milk that contained all the nutritional…

WednesdayJan 20, 2021 1:30 pm

Magnetic Nanoparticles May Be Used to Improve Cancer Treatment in the Near Future

A team of researchers from the University College London has demonstrated how small magnetic nanoparticles can be used to improve cancer treatment. Those nanoparticles can transport chemo drugs to cancer cells while also generating a minimal heating effect once stimulated through the use of an alternating external magnetic field. The combination of chemotherapy and particle-mediated heat treatment brings about synergistic effects in the elimination of cancer cells. This proposes that the technology may be a useful tool in the fight against cancer. The nanoparticles are made from iron oxide, which make them magnetic. These particles can be stimulated to generate…

TuesdayJan 19, 2021 11:30 am

Ultrasound, Nanodroplets to Be Used in Eliminating Difficult Blood Clots

Every year, anywhere from 300,000 to 600,000 individuals are affected by deep vein thromboses in the United States. One of the major obstacles of vascular surgery has been penetrating extensive and compacted blood clots. This is mainly because the retracted clots are of low porosity and high density. While there are tools such as catheter-based devices that have been created for that specific purpose and are being used today, the challenge still presents itself in patients with plaques that are too difficult to penetrate, even for the best devices in existence. However, there may be an alternative as researchers from…

FridayJan 15, 2021 10:03 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Offers Significant Advantages Over Current Standard Of Visualizing Bladder Cancer During Surgery

The number of bladder cancer cases in 2020 is estimated at 81,400, nearly 4.5% of all newly diagnosed cancer cases, and the current bladder cancer research market is projected to grow at a CAGR of 4.03% through 2026 White light, the most widely accepted current standard of care for bladder cancer removal, may not be the best option in helping to prevent recurrence, leaving hundreds of thousands of patients afraid of relapse Blue light has been introduced and proven to detect 25% more tumors, but because of limitations, has not been widely accepted Imagin Medical’s i/Blue Imaging System(TM) can be…

ThursdayJan 14, 2021 12:38 pm

Brain Scientific (BRSF) Plans to Enter New Markets While Making EEGs More Accessible

Ease of use, compatibility with third-party EEG amplifiers has created diverse target markets for BRSF’s NeuroCap Recent forecasts show telemedicine industry expected to experience CAGR of 15.1% through 2027 BRSF has potential to disrupt sleep industry, which is forecast to reach $585 billion by 2025 Brain Scientific (OTCQB: BRSF) is offering solutions to the EEG industry’s limitations. The current method of administering an EEG is slow and expensive, plus requires specialized EEG technologists and bulky equipment. This essential procedure is not easily accessible to all, particularly those in rural communities, because of the expense and a neurologist shortage. The NeuroCap(TM)…

ThursdayJan 14, 2021 12:30 pm

Cooling Vests May Be Solution to PPE Discomfort for COVID-19 Healthcare Personnel

A team of scientists from the Radboud University Medical Center have tested out cooling vests that were initially designed for elite athletes on nursing staff who work long shifts in coronavirus wards wearing personal protective equipment (PPE). While PPE is essential, it can cause discomfort. The majority of the staff in the facility reported that they felt more comfortable with the vest on because it combats heat stress. The vest is now part of the center’s standard equipment. PPE’s are important as they help keep healthcare personnel, who are on the frontline of duty, safe during the coronavirus pandemic. However,…

WednesdayJan 13, 2021 2:30 pm

Scientists Trying to Eliminate Main Cause of Food Allergies

In the United States, 2% of grown-ups and nearly 7% of kids suffer from a food allergy. Annually, these allergies cost individuals time spent away from work or school and $25 billion in health care. In addition to this, some individuals develop serious complications from their allergies that may sometimes result in death. It’s important to discover ways to reduce the distress caused by food allergies. Companies that process food have already gone the extra mile to indicate ingredients on product labels to help people avoid items they may be allergic to. However, it may be possible to instead but…

WednesdayJan 13, 2021 12:15 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Moving Forward with New Berubicin Clinical Trials, Determined to Help Address Unmet Needs of GBM Patients

IND approval from the FDA has given CNS Pharmaceuticals the green light needed to continue with clinical research of Berubicin in patients suffering from GBM and other brain/nervous system cancers Company holds the exclusive worldwide license for Berubicin, the first anthracycline to cross the blood-brain barrier in the adult brain The GBM therapeutics market is expected to increase to an estimated $3.3 billion in 2024 CNS Pharmaceuticals’ sublicensee will be conducting the first pediatric study using Berubicin CNS Pharmaceuticals (NASDAQ: CNSP) is a clinical-stage biotechnology company that is currently specializing in the development of novel treatments for primary and metastatic…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Artificial Intelligence Could Improve IVF Outcomes

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Disrupting Global Agricultural Markets

Tired of Dairy? Tel Aviv Researchers May Have Just What You Need, Milk From Yeast!

Magnetic Nanoparticles May Be Used to Improve Cancer Treatment in the Near Future

Ultrasound, Nanodroplets to Be Used in Eliminating Difficult Blood Clots

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Offers Significant Advantages Over Current Standard Of Visualizing Bladder Cancer During Surgery

Brain Scientific (BRSF) Plans to Enter New Markets While Making EEGs More Accessible

Cooling Vests May Be Solution to PPE Discomfort for COVID-19 Healthcare Personnel

Scientists Trying to Eliminate Main Cause of Food Allergies

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Moving Forward with New Berubicin Clinical Trials, Determined to Help Address Unmet Needs of GBM Patients

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search